CAPLACIZUMAB
CAPLACIZUMAB is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as human prescription drug products.
About CAPLACIZUMAB
CAPLACIZUMAB appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Genzyme Corporation. Approved labelling for these products most frequently references: treatment adult, pediatric patients, years age, acquired thrombotic, thrombocytopenic purpura, attp combination, plasma exchange, immunosuppressive therapy. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Genzyme Corporation | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing CAPLACIZUMAB
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| Cablivi | Genzyme Corporation | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products contain CAPLACIZUMAB?
1 FDA drug label records list CAPLACIZUMAB as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make CAPLACIZUMAB products?
The manufacturers with the most CAPLACIZUMAB label records are Genzyme Corporation. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.